$MRNA Moderna Reports Positive Interim Phase I Results for COVID-19 Vaccine Moderna released interim Phase I data showing that all 45 participants across the study’s three dose levels produced antibodies of the virus by day 15 following treatment with a single dose, while eight of the participants in two of the dose levels reached or exceeded neutralizing antibody titers generally seen in convalescent sera based on two doses as of day 43. + MORE
  • 1
1 Like